# Levosimendan in High Risk Heart Valve Surgery

> **NCT00154115** · PHASE4 · COMPLETED · sponsor: **Kuopio University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** levosimendan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00154115
- **Lead sponsor:** Kuopio University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154115, "Levosimendan in High Risk Heart Valve Surgery". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00154115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*